A Population-based Case-control Teratological Study of Oral Nystatin Treatment During Pregnancy
Autor: | Elisabeth Puho, Andrew E. Czeizel, Zoltán Kazy |
---|---|
Rok vydání: | 2003 |
Předmět: |
Male
Nystatin Administration Oral Pregnancy Reference Values Oral administration Oral nystatin Odds Ratio Birth Weight Registries Pregnancy Complications Infectious Hypospadias education.field_of_study Obstetrics Incidence Pregnancy Outcome Abnormalities Drug-Induced General Medicine humanities Teratogens Infectious Diseases embryonic structures Gestation Female Infant Premature medicine.drug Adult Microbiology (medical) medicine.medical_specialty animal structures Population Gestational Age Population based Risk Assessment Drug Administration Schedule Confidence Intervals medicine Humans education Probability Gynecology Dose-Response Relationship Drug General Immunology and Microbiology business.industry Infant Newborn Case-control study medicine.disease Case-Control Studies business Follow-Up Studies |
Zdroj: | Scandinavian Journal of Infectious Diseases. 35:830-835 |
ISSN: | 1651-1980 0036-5548 |
DOI: | 10.1080/00365540310017069 |
Popis: | The aim of the study was to investigate the teratogenicity of oral nystatin treatment during pregnancy in the population-based data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities between 1980 and 1996. In total, 38,151 pregnant women who delivered newborn infants without any defects (control group) and 22,843 pregnant women who had foetuses or newborns with congenital abnormalities (CA) (case group) were included in the study. 106 (0.5%) case and 143 (0.4%) control pregnant women were treated with oral nystatin (crude OR with 95% CI = 1.2, 1.0-1.6). A teratogenic potential of nystatin was seen in 1 CA-group (hypospadias) in 2 different approaches of the study (case-control and total control--CA groups comparison) during the critical period of this congenital abnormality. The conclusion of the study is that treatment with oral nystatin during pregnancy presents little teratogenic risk to the foetus, but the possible association between hypospadias and nystatin needs further study. |
Databáze: | OpenAIRE |
Externí odkaz: |